Crossmark

Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis

Crossref DOI link: https://doi.org/10.1186/s12944-021-01431-x

Published Online: 2021-01-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feder, Susanne

Wiest, Reiner

Weiss, Thomas S.

Aslanidis, Charalampos

Schacherer, Doris

Krautbauer, Sabrina

Liebisch, Gerhard

Buechler, Christa http://orcid.org/0000-0002-5635-3994
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (BU 1141/13-1)
License Information

Text and Data Mining valid from 2021-01-18

Version of Record valid from 2021-01-18
More Information

Article History

Received: 8 September 2020

Accepted: 7 January 2021

First Online: 18 January 2021

Ethics approval and consent to participate

: The manuscript or parts of it were not published or submitted elsewhere. The study was performed according to the updated guidelines of good clinical practice and Declaration of Helsinki. Informed consent was obtained from all patients.

: Not applicable.

: The authors have no competing interests.

Document is current

Any future updates will be listed below